ES2061582T3 - Procedimiento para producir una proteina de factor viii:c humano recombinante. - Google Patents

Procedimiento para producir una proteina de factor viii:c humano recombinante.

Info

Publication number
ES2061582T3
ES2061582T3 ES88114769T ES88114769T ES2061582T3 ES 2061582 T3 ES2061582 T3 ES 2061582T3 ES 88114769 T ES88114769 T ES 88114769T ES 88114769 T ES88114769 T ES 88114769T ES 2061582 T3 ES2061582 T3 ES 2061582T3
Authority
ES
Spain
Prior art keywords
factor viii
human factor
recombinant human
producing
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88114769T
Other languages
English (en)
Inventor
Takashi Sugiyama
Kenichi Masuda
Yoshitaka Tajima
Hiroshi Yonemura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemo Sero Therapeutic Research Institute Kaketsuken
Teijin Ltd
Original Assignee
Chemo Sero Therapeutic Research Institute Kaketsuken
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeutic Research Institute Kaketsuken, Teijin Ltd filed Critical Chemo Sero Therapeutic Research Institute Kaketsuken
Application granted granted Critical
Publication of ES2061582T3 publication Critical patent/ES2061582T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

UN TRANSFORMANTE DE CELULAS ANIMALES PREFERIBLEMENTE CELULAS DE CHO, QUE ES PRODUCIDO TRANSFORMANDO CELULAS ANIMALES CON UN VECTOR DE EXPRESION QUE CONTIENE UN GEN QUE CODIFICA UN FACTOR HUMANO ACTIVO TIPO NATURAL VIII:C Y ARRASTRE DE ESTO AL MENOS UN PROMOTOR Y CONTIENE OPCIONALMENTE ADEMAS AL MENOS UN ACELERADOR. UNO DE LOS TRANSFORMANTES DE CELULAS CHO CONTIENE UN VECTOR DE EXPRESION CONTENIENDO UN GEN QUE CODIFICA 740 - ARG - 1649 GEN FACTOR VIII:C. ADEMAS, UN METODO PARA PRODUCIR FACTOR VIII:C HUMANO RECOMBINANTE, PREFERIBLEMENTE 740 - ARG - 1649 GEN. FACTOR VIII:C, QUE COMPRENDE CULTIVAR EL TRANSFORMANTE EN UN MEDIO, PREFERIBLEMENTE EN PRESENCIA DE FACTOR VON WILLEBRAND, ALBRIMINA, POLIETILENGLICOL, SELENITO DE SODIO, ACIDO E - AMINOCAPROICO, PMSF, APROTIMINA O CICLODEXTRINAS, Y RECUPERACION DEL FACTOR HUMANO ACTIVO TIPO NATURAL VIII:C RECOMBINANTE ACUMULADO EN EL MEDIO DE CULTIVO.
ES88114769T 1987-09-10 1988-09-09 Procedimiento para producir una proteina de factor viii:c humano recombinante. Expired - Lifetime ES2061582T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP22514787 1987-09-10
JP63085454A JPH0387173A (ja) 1987-09-10 1988-04-08 ヒト活性化天然型ファクター８ｃの製造方法及びそれに用いる形質転換体

Publications (1)

Publication Number Publication Date
ES2061582T3 true ES2061582T3 (es) 1994-12-16

Family

ID=26426457

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88114769T Expired - Lifetime ES2061582T3 (es) 1987-09-10 1988-09-09 Procedimiento para producir una proteina de factor viii:c humano recombinante.

Country Status (9)

Country Link
EP (1) EP0306968B1 (es)
JP (1) JPH0387173A (es)
KR (1) KR950012804B1 (es)
AT (1) ATE97957T1 (es)
AU (1) AU627432B2 (es)
CA (1) CA1341236C (es)
DE (1) DE3885983T2 (es)
ES (1) ES2061582T3 (es)
NZ (1) NZ226082A (es)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595886A (en) 1986-01-27 1997-01-21 Chiron Corporation Protein complexes having Factor VIII:C activity and production thereof
WO1990002175A1 (en) * 1988-08-16 1990-03-08 Novo Nordisk A/S A method of producing polypeptides by culturing eukaryotic cells in the presence of protease inhibitors
EP0410207B1 (en) * 1989-07-24 1997-01-22 Bayer Corporation Stabilization of highly purified proteins
ES2047946T3 (es) * 1989-08-11 1994-03-01 Zymogenetics Inc Metodos de cultivos celulares para producir proteina c activada.
FR2657884B1 (fr) * 1990-02-05 1994-09-02 Tm Innovation Procede pour la preparation du facteur viii humain et d'analogues du facteur viii.
US5378612A (en) * 1990-05-11 1995-01-03 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Culture medium for production of recombinant protein
US6376463B1 (en) 1992-04-07 2002-04-23 Emory University Modified factor VIII
US5859204A (en) * 1992-04-07 1999-01-12 Emory University Modified factor VIII
US6180371B1 (en) 1996-06-26 2001-01-30 Emory University Modified factor VIII
US5888974A (en) * 1992-04-07 1999-03-30 Emory University Hybrid human/animal factor VIII
US5851800A (en) * 1996-05-14 1998-12-22 Pharmacia & Upjohn Ab Process for producing a protein
US7560107B2 (en) 1996-06-26 2009-07-14 Emory University Modified factor VIII
US6458563B1 (en) 1996-06-26 2002-10-01 Emory University Modified factor VIII
US5804420A (en) * 1997-04-18 1998-09-08 Bayer Corporation Preparation of recombinant Factor VIII in a protein free medium
JP2002524473A (ja) * 1998-09-09 2002-08-06 ジエンザイム コーポレイション プラスミドベクターのメチル化
JP5149470B2 (ja) 1999-02-22 2013-02-20 バクスター・インターナショナル・インコーポレイテッド 新規のアルブミンを含有していない第ｖｉｉｉ因子処方物
DK1750733T3 (da) 2004-05-03 2014-01-20 Univ Emory FREMGANGSMÅDE TIL INDGIVELSE AF SVINE-B-DOMÆNELØS fVIII
JP4769034B2 (ja) * 2005-07-08 2011-09-07 大東榮紙工株式会社 食品収納容器
US7985839B2 (en) 2006-03-31 2011-07-26 Baxter International Inc. Factor VIII polymer conjugates
US7645860B2 (en) 2006-03-31 2010-01-12 Baxter Healthcare S.A. Factor VIII polymer conjugates
US7982010B2 (en) 2006-03-31 2011-07-19 Baxter International Inc. Factor VIII polymer conjugates
KR20080108147A (ko) 2006-03-31 2008-12-11 백스터 인터내셔널 인코포레이티드 페질화된 인자 ｖｉｉｉ
ES2521490T3 (es) 2006-12-15 2014-11-12 Baxter International Inc. Conjugado de factor VIIa - ácido (poli)siálico con una vida media in vivo prolongada.
CN101646779B (zh) 2007-02-23 2014-12-03 Sk化学株式会社 制备和纯化因子viii及其衍生物的方法
EP2349341B1 (en) 2008-10-15 2013-10-09 Baxter Healthcare SA Pegylation of recombinant blood coagulation factors in the presence of bound antibodies
NZ593190A (en) 2008-11-07 2013-01-25 Baxter Int Factor viii formulations
KR101832937B1 (ko) 2009-07-27 2018-02-28 박스알타 인코퍼레이티드 혈액 응고 단백질 복합체
SG10201401194VA (en) 2009-07-27 2014-07-30 Lipoxen Technologies Ltd Glycopolysialylation of non-blood coagulation proteins
US8642737B2 (en) 2010-07-26 2014-02-04 Baxter International Inc. Nucleophilic catalysts for oxime linkage
ES2590679T3 (es) 2009-07-27 2016-11-23 Lipoxen Technologies Limited Glicopolisialilación de proteínas diferentes a proteínas de coagulación de la sangre
US8809501B2 (en) 2009-07-27 2014-08-19 Baxter International Inc. Nucleophilic catalysts for oxime linkage
US8765432B2 (en) 2009-12-18 2014-07-01 Oligasis, Llc Targeted drug phosphorylcholine polymer conjugates
CN103370082A (zh) 2010-07-30 2013-10-23 巴克斯特国际公司 用于肟键联的亲核性催化剂
MX347503B (es) 2010-11-05 2017-04-26 Baxalta Inc Una variante nueva del factor viii antihemofílico que tiene actividad específica incrementada.
EA032056B1 (ru) 2010-12-22 2019-04-30 Баксалта Инкорпорейтид Конъюгат терапевтического белка и производного жирной кислоты, способы получения конъюгата терапевтического белка и производного жирной кислоты (варианты)
AU2013204754C1 (en) 2012-05-16 2018-10-11 Takeda Pharmaceutical Company Limited Nucleophilic Catalysts for Oxime Linkage
SI3041513T1 (sl) 2013-09-08 2020-11-30 Kodiak Sciences Inc. Zwitterionski polimerni konjugati faktorja VIII
KR102670157B1 (ko) 2015-10-28 2024-05-29 주식회사유한양행 이중 작용 단백질 및 이를 포함하는 약학적 조성물
KR102668200B1 (ko) 2015-10-28 2024-05-23 주식회사유한양행 지속형 fgf21 융합 단백질 및 이를 포함하는 약학적 조성물
EP3167877A1 (en) 2015-11-12 2017-05-17 Bayer Pharma Aktiengesellschaft Method for the production of freeze-dried pellets comprising factor viii
CN108884146A (zh) 2015-12-03 2018-11-23 百深公司 具有延长的半衰期及降低的配体结合性质的因子viii
AU2017358289A1 (en) 2016-11-10 2019-06-20 Yuhan Corporation Pharmaceutical composition for preventing or treating hepatitis, hepatic fibrosis, and hepatic cirrhosis comprising fusion proteins
MX2019012331A (es) 2017-04-21 2020-01-23 Yuhan Corp Metodo para producir proteinas de doble funcion y sus derivados.
WO2020185543A1 (en) 2019-03-08 2020-09-17 Mevion Medical Systems, Inc. Collimator and energy degrader for a particle therapy system
CA3157509A1 (en) 2019-10-10 2021-04-15 Kodiak Sciences Inc. Methods of treating an eye disorder

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI86885C (fi) * 1984-04-20 1992-10-26 Genentech Inc Foerfarande foer framstaellning av human rekombinantfaktor viii och nukleinsyrasekvenser och vektorer anvaend daertill
EP0218712B1 (en) * 1985-04-12 1992-02-26 Genetics Institute, Inc. Novel procoagulant proteins
KR910006424B1 (ko) * 1985-08-21 1991-08-24 인코텍스 비.브이 편성브리프(brief) 제조방법
JP2525022B2 (ja) * 1986-01-03 1996-08-14 ジェネティックス・インスチチュ−ト・インコ−ポレ−テッド ▲ＶＩＩＩ▼：ｃ因子型タンパク質の改良生産方法
FI98829C (fi) * 1986-01-27 1997-08-25 Chiron Corp Menetelmä rekombinoidun proteiinikompleksin valmistamiseksi, jolla on humaanitekijä VIII:C-aktiivisuutta
WO1988005825A1 (en) * 1987-01-30 1988-08-11 Biogen N.V. A method for producing factor viii in high yield
IL86693A (en) * 1987-06-12 1994-06-24 Stichting Centraal Lab Proteins that have the activity IIIV of the blood, a process for their preparation that uses cells are produced through genetic engineering and pharmaceutical preparations that contain them

Also Published As

Publication number Publication date
EP0306968A3 (en) 1989-04-12
EP0306968B1 (en) 1993-12-01
NZ226082A (en) 1990-09-26
AU2200388A (en) 1989-03-16
DE3885983T2 (de) 1994-06-23
EP0306968A2 (en) 1989-03-15
AU627432B2 (en) 1992-08-27
KR950012804B1 (ko) 1995-10-21
JPH0387173A (ja) 1991-04-11
DE3885983D1 (de) 1994-01-13
CA1341236C (en) 2001-05-22
KR890005268A (ko) 1989-05-13
ATE97957T1 (de) 1993-12-15

Similar Documents

Publication Publication Date Title
ES2061582T3 (es) Procedimiento para producir una proteina de factor viii:c humano recombinante.
DK488386D0 (da) Human-metallothionein-ii promotor i pattedyrekspressionssystemer
ES2072893T3 (es) Endoproteasa kex2 y procedimiento para su produccion.
DE68916537D1 (de) Herstellung eines insulinähnlichen, wachstümsfaktor bindenden proteins.
ATE177473T1 (de) Herstellung von rekombinanten, menschlichem lactoferrin
SE8105657L (sv) Mikrobiell framstellning av humanfibroblastinterferon
DE3650538D1 (de) Interleukin-4 protein mit bcgf- und tcgf-aktivität gegenüber menschlichen zellen (menschliches interleukin-4)
ATE364703T1 (de) Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen
ATE268783T1 (de) Expression in der selben zelle von polypeptide vom schweinen reproduktiven und respiratorischen syndrom
DK163930C (da) Biologisk aktivt peptid og peptidfragment deraf med natriuretisk, diuretisk og vasodilataterende aktivitet og terapeutisk middel indeholdende et saadant peptid eller peptidfragment
IT8421436A0 (it) Proteina cosi' prodotta. un plasmide ricombinante, un microorganismo trasformante un segmento di polideossiribonucleotide, un procedimento per produrre una proteina biologicamente attiva e la
ES2108681T3 (es) Expresion de la albumina del suero humano en las levaduras metilotroficas.
DE69032043D1 (de) Proteinkomplexe mit faktor viii:c-aktivität und deren herstellung
DK619086D0 (da) Gm-csf-protein, derivater deraf, samt fremstilling og anvendelse af saadanne proteiner
HUT50195A (en) New peptites hindering the activity of immune system and medical compositions containing them and process for production of these peptides and compositions
ATE26999T1 (de) Verfahren zur herstellung von menschlichem fibroblasten-interferon.
AU6707686A (en) Prostate-derived growth factor
IL82207A0 (en) Production of peptides,recombinant plasmid used therefor and animal cells transformed therewith
ES2078229T3 (es) Procedimiento para la preparacion de un polipeptido similar a la motilina y su expresion.
DE69220259D1 (de) Verfahren zur Herstellung von menschlichem NGF-2
DE3650477D1 (de) Produktion von Cystinreste enthaltenden aktiven Proteinen
DK0414151T3 (da) Humane nervevæskstfaktorproteiner og fremstilling deraf
ATE291629T1 (de) Expressionssystem für die sekretion von bioaktivem, menschlichem granulozyt-makrophagem koloniestimulierungsfaktor (gm-csf) und anderen heterologen proteinen aus streptomyces
ATE141093T1 (de) Polypeptid

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 306968

Country of ref document: ES